According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...
Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...
Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new sterile manufacturing facility.
Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.
(MENAFN- GlobeNewsWire - Nasdaq) This course explores Annex 1's requirements, focusing on aseptic operations, CCS, and quality assurance. Attendees gain insights into regulatory expectations, ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results